Jun. 30, 2022
Jun. 29, 2022
SKYRIZI® (risankizumab-rzaa) Receives FDA Approval
Jun. 29, 2022
Moderna Announces Omicron-Containing Bivalent Booster Candidate mRNA-1273.214 Demonstrates Superior Antibody Response Against Omicron
Jun. 29, 2022
FDA Approves First Systemic Treatment for Alopecia Areata
Jun. 29, 2022
Nurse Leader Fundamentals: On-Demand Workshop and Tools Package
Jun. 29, 2022
Examining Nursing Home Information Technology Maturity and Antibiotic Use Among Long-Term Care Residents
Jun. 28, 2022
Two Omicron Subvariants Spreading Across US
Jun. 28, 2022
Pulse Oximeter Accuracy and Limitations: FDA Safety Communication
Jun. 28, 2022
COVID Death Rate for White Americans Now Exceeds Others: Report
Jun. 28, 2022